NYSE:CCChemicals
Is Chemours (CC) A Bargain As Its PFAS Settlement Clarifies Long Term Risks?
Chemours (CC) stock is in focus after the company agreed to a regulatory settlement over PFAS discharges, committing to a US$22.5 million civil penalty and US$90 million of long term mitigation projects.
See our latest analysis for Chemours.
The PFAS settlement landed after a strong run for Chemours, with the share price up 64.41% year to date at US$20.14. However, recent 30 day and 7 day share price returns of 9.77% and 4.87% respectively indicate that momentum has cooled and reflect longer...